Samarth Kulkarni - Mar 20, 2024 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role: Chief Executive Officer, Director
Signature: /s/ AJ Silver, attorney-in-fact
Stock symbol: CRSP
Transactions as of: Mar 20, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/22/2024, 05:45 PM
Previous filing: Mar 18, 2024
Next filing: Apr 17, 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRSP	Stock Option (Right to Buy)	Award	$0	+105K		$0.00	105K	Mar 20, 2024	Common Shares	105K	$72.94	Direct	F1
transaction	CRSP	Restricted Stock Units	Award	$0	+78.8K		$0.00	78.8K	Mar 20, 2024	Common Shares	78.8K		Direct	F2, F3

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on March 20, 2024 with respect to 105,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2024.
F2	Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
F3	This restricted stock unit award was granted on March 20, 2024 with respect to 78,750 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028.